PHIO:NASDAQ
Phio Pharmaceuticals Corp
$1.08
arrow_upward
+2.36%(+0.025) 1D
Aug 11, 1:15:20 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHIO...
Open
$1.07
High
$1.10
Low
$1.07
Mkt. cap
12.60M
Avg. vol.
1.08M
Volume
181.53K
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.49
Beta
0.82
Shares outstanding
11.62M
No. of employees
6
Open
$1.07
High
$1.10
Low
$1.07
Mkt. cap
12.60M
Avg. vol.
1.08M
Volume
181.53K
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.49
Beta
0.82
Shares outstanding
11.62M
No. of employees
6
News stories
From web sources and news partners
Investing.com
·
5 hours ago
Phio Pharmaceuticals receives U.S. patent allowance for PH-894
TMX Newsfile
·
6 hours ago
Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
Stock Titan
·
6 hours ago
Phio's PH-894 Patent Allowance Spans Proliferative and Infectious Diseases
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp
AI content may include mistakes. Learn more